Peritoneal surface malignancies (PSMs) are usually associated with a poor prognosis.
Nonetheless, in line with advances in the management of most abdominopelvic metastatic …

Peritoneal metastasis (PM) originating from gastrointestinal and gynecological malignancies
are associated with a poor prognosis and rapid disease progression. Cytoreductive surgery …

Background: Cytoreductive surgery (CRS), followed by hyperthermic intraperitoneal
chemotherapy (HIPEC), combines radical surgery with abdominal heated chemotherapy …

Intraperitoneal chemotherapy is associated with a significant pharmacokinetic and
pharmacodynamic benefit and can, alone or in combination with systemic chemotherapy …

Aim: The aim of this study was to assess the outcomes of patients operated on for peritoneal
metastases from unusual cancer sites of origin, meaning apart from peritoneal metastases …

Background: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)
achieve good results in selected patients with peritoneal carcinomatosis. High intra …

BACKGROUND Cytoreductive surgery (CRS) with hyperthermic intraperitoneal
chemotherapy (HIPEC) for peritoneal carcinomatosis can be performed in two ways: Open …

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
combined have been recognized as standard of care for treatment of a subset of patients …

Background. Peritoneal carcinomatosis (PC) is associated with a poor prognosis.
Cytoreductive surgery (CRS) and HIPEC play an important role in well‐selected patients …

Simple Summary Efficacy of cytoreductive surgery (CRS) combined with hyperthermic
intraperitoneal chemotherapy (HIPEC) depends on patient selection, tumor type, delivery …